-
EN
EN
About Us
Ron Liu is the founder of the company, and is currently the Chairman and CEO of the company. He has devoted himself into the development and industrialization of pharmaceutical formulation technologies for over 30 years, has been engaged in the R&D and management of pharmaceutical formulation technologies in Wyeth (now Pfizer), Abbott and Bristol-Myers Squibb, and has founded AustarPharma in the United States. He is also a member of the Review Committee of New Drug Release Technology, National Institutes of Health (NIH), and a candidate of the national major projects for talent development.
Tony Tong is currently the President and Chief Scientific Officer of the company. He has more than 30 years of research experience in the development and industrialization of pharmaceutical formulation technologies, used to work in the field of drug development and management at GlaxoSmithKline and Novartis in the United States, and served as the Vice President of R&D in North America for Teva Pharmaceuticals from 2002 to 2008. He has been awarded with the titles of “Leading Innovation Talent of Guangzhou”, and “Outstanding Talent of Guangzhou Development District”.
Dillon Gao is the Chief Business Officer of the company. He has nearly 20 years of management experience in foreign enterprises and experience in business development， joint venture and technology licensing. He is also a core member of the innovation and entrepreneurship team in Guangdong Province, and has been awarded with the title of “Elite Talent of Guangzhou Development District”.
William Li is the Sr. Vice President of formulation at Bostal. He has over 15 years of working experience in the US and China. Multiple products developed under his leadership have been successfully approved in the United stated and China. He is also a core member of the innovation and entrepreneurship team of Guangdong Province, and was awarded with the title of "Elite Talent of Guangzhou Development District".
David Wu is currently the Vice President of Production of the company. He has been engaged in pharmaceutical research and industrialization development for over 20 years, has worked for several well-known domestic and international pharmaceutical enterprises, such as Apollo, Lifetech Pharmaceuticals, and Sanofi, and has been responsible for the construction of many pharmaceutical factories. He is also a core member of the Guangzhou entrepreneurial team.
Bihui Liu is currently the Vice President of Quality Management. She has been engaged in drug quality management for over 30 years, has served as the deputy general manager in China Otsuka Pharmaceutical Co., Ltd., a Japanese multinational company, and is responsible for the construction and management of the quality system.